EGA® “Side Car” study Participation
General Discription
EGA® “Side Car” study is open to “accredited” investors (that have the appropriate health to participate) looking to assess EGA® and Egaceutical Corporation for possible investment into Egaceutical’s Reg D 506c SEC registered offering.
Participant agrees to:
A minimum of 16 weeks of participation
Payment for EGA®
Payment for Diagnostic Testing
Minimum blood testing is: IL-6. TNF-alpha, CRP, CMV-IgG, fasting insulin and glucose.
To follow study protocol
To follow study EGA® dosing
To follow study testing times and dates
To follow study self-reporting
To allow Egaceutical access to all relevant medical information needed for study